nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Neuritis—Vinblastine—head and neck cancer	0.0336	0.0439	CcSEcCtD
Cyproheptadine—Chest tightness—Docetaxel—head and neck cancer	0.0254	0.0332	CcSEcCtD
Cyproheptadine—Hepatic failure—Hydroxyurea—head and neck cancer	0.0185	0.0242	CcSEcCtD
Cyproheptadine—Neuritis—Docetaxel—head and neck cancer	0.0159	0.0208	CcSEcCtD
Cyproheptadine—Euphoric mood—Fluorouracil—head and neck cancer	0.0142	0.0185	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0138	0.018	CcSEcCtD
Cyproheptadine—Photosensitivity—Fluorouracil—head and neck cancer	0.0136	0.0178	CcSEcCtD
Cyproheptadine—Chest discomfort—Docetaxel—head and neck cancer	0.0134	0.0176	CcSEcCtD
Cyproheptadine—Agranulocytosis—Vinblastine—head and neck cancer	0.0131	0.0171	CcSEcCtD
Cyproheptadine—Weight increased—Hydroxyurea—head and neck cancer	0.0131	0.0171	CcSEcCtD
Cyproheptadine—Drowsiness—Hydroxyurea—head and neck cancer	0.0128	0.0167	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0125	0.0164	CcSEcCtD
Cyproheptadine—Hallucination—Hydroxyurea—head and neck cancer	0.0114	0.015	CcSEcCtD
Cyproheptadine—Irritability—Fluorouracil—head and neck cancer	0.0114	0.0149	CcSEcCtD
Cyproheptadine—Chills—Hydroxyurea—head and neck cancer	0.0103	0.0135	CcSEcCtD
Cyproheptadine—Vertigo—Vinblastine—head and neck cancer	0.00986	0.0129	CcSEcCtD
Cyproheptadine—Leukopenia—Vinblastine—head and neck cancer	0.00982	0.0128	CcSEcCtD
Cyproheptadine—Hepatic failure—Docetaxel—head and neck cancer	0.0096	0.0126	CcSEcCtD
Cyproheptadine—Convulsion—Vinblastine—head and neck cancer	0.0095	0.0124	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00943	0.0123	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00903	0.0118	CcSEcCtD
Cyproheptadine—Leukopenia—Hydroxyurea—head and neck cancer	0.00895	0.0117	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00877	0.0115	CcSEcCtD
Cyproheptadine—Convulsion—Hydroxyurea—head and neck cancer	0.00867	0.0113	CcSEcCtD
Cyproheptadine—Agranulocytosis—Fluorouracil—head and neck cancer	0.0086	0.0112	CcSEcCtD
Cyproheptadine—Anorexia—Vinblastine—head and neck cancer	0.00853	0.0112	CcSEcCtD
Cyproheptadine—Oedema—Hydroxyurea—head and neck cancer	0.00816	0.0107	CcSEcCtD
Cyproheptadine—Paraesthesia—Vinblastine—head and neck cancer	0.00804	0.0105	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00799	0.0105	CcSEcCtD
Cyproheptadine—Anorexia—Hydroxyurea—head and neck cancer	0.00778	0.0102	CcSEcCtD
Cyproheptadine—Decreased appetite—Vinblastine—head and neck cancer	0.00778	0.0102	CcSEcCtD
Cyproheptadine—Constipation—Vinblastine—head and neck cancer	0.00766	0.01	CcSEcCtD
Cyproheptadine—Feeling abnormal—Vinblastine—head and neck cancer	0.00738	0.00965	CcSEcCtD
Cyproheptadine—Somnolence—Hydroxyurea—head and neck cancer	0.00726	0.00949	CcSEcCtD
Cyproheptadine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00719	0.0094	CcSEcCtD
Cyproheptadine—Decreased appetite—Hydroxyurea—head and neck cancer	0.0071	0.00928	CcSEcCtD
Cyproheptadine—Fatigue—Hydroxyurea—head and neck cancer	0.00704	0.0092	CcSEcCtD
Cyproheptadine—Constipation—Hydroxyurea—head and neck cancer	0.00698	0.00913	CcSEcCtD
Cyproheptadine—Weight increased—Docetaxel—head and neck cancer	0.00679	0.00888	CcSEcCtD
Cyproheptadine—Vision blurred—Fluorouracil—head and neck cancer	0.00679	0.00887	CcSEcCtD
Cyproheptadine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00673	0.0088	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00652	0.00852	CcSEcCtD
Cyproheptadine—Jaundice—Docetaxel—head and neck cancer	0.00648	0.00848	CcSEcCtD
Cyproheptadine—Leukopenia—Fluorouracil—head and neck cancer	0.00645	0.00843	CcSEcCtD
Cyproheptadine—Asthenia—Vinblastine—head and neck cancer	0.00642	0.0084	CcSEcCtD
Cyproheptadine—Convulsion—Fluorouracil—head and neck cancer	0.00624	0.00816	CcSEcCtD
Cyproheptadine—Agranulocytosis—Docetaxel—head and neck cancer	0.00621	0.00812	CcSEcCtD
Cyproheptadine—Diarrhoea—Vinblastine—head and neck cancer	0.00613	0.00801	CcSEcCtD
Cyproheptadine—Hepatitis—Docetaxel—head and neck cancer	0.00597	0.00781	CcSEcCtD
Cyproheptadine—Confusional state—Fluorouracil—head and neck cancer	0.00593	0.00775	CcSEcCtD
Cyproheptadine—Dizziness—Vinblastine—head and neck cancer	0.00592	0.00774	CcSEcCtD
Cyproheptadine—Oedema—Fluorouracil—head and neck cancer	0.00588	0.00768	CcSEcCtD
Cyproheptadine—Asthenia—Hydroxyurea—head and neck cancer	0.00586	0.00766	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00575	0.00752	CcSEcCtD
Cyproheptadine—Tachycardia—Fluorouracil—head and neck cancer	0.00574	0.0075	CcSEcCtD
Cyproheptadine—Vomiting—Vinblastine—head and neck cancer	0.00569	0.00744	CcSEcCtD
Cyproheptadine—Headache—Vinblastine—head and neck cancer	0.00561	0.00733	CcSEcCtD
Cyproheptadine—Anorexia—Fluorouracil—head and neck cancer	0.0056	0.00732	CcSEcCtD
Cyproheptadine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00559	0.0073	CcSEcCtD
Cyproheptadine—Hypotension—Fluorouracil—head and neck cancer	0.00549	0.00718	CcSEcCtD
Cyproheptadine—Dizziness—Hydroxyurea—head and neck cancer	0.0054	0.00706	CcSEcCtD
Cyproheptadine—Chills—Docetaxel—head and neck cancer	0.00536	0.007	CcSEcCtD
Cyproheptadine—Nausea—Vinblastine—head and neck cancer	0.00532	0.00695	CcSEcCtD
Cyproheptadine—Insomnia—Fluorouracil—head and neck cancer	0.00532	0.00695	CcSEcCtD
Cyproheptadine—Paraesthesia—Fluorouracil—head and neck cancer	0.00528	0.0069	CcSEcCtD
Cyproheptadine—Somnolence—Fluorouracil—head and neck cancer	0.00522	0.00683	CcSEcCtD
Cyproheptadine—Vomiting—Hydroxyurea—head and neck cancer	0.00519	0.00679	CcSEcCtD
Cyproheptadine—Dyspepsia—Fluorouracil—head and neck cancer	0.00517	0.00676	CcSEcCtD
Cyproheptadine—Rash—Hydroxyurea—head and neck cancer	0.00515	0.00673	CcSEcCtD
Cyproheptadine—Dermatitis—Hydroxyurea—head and neck cancer	0.00514	0.00672	CcSEcCtD
Cyproheptadine—Headache—Hydroxyurea—head and neck cancer	0.00511	0.00669	CcSEcCtD
Cyproheptadine—Decreased appetite—Fluorouracil—head and neck cancer	0.00511	0.00668	CcSEcCtD
Cyproheptadine—Nausea—Hydroxyurea—head and neck cancer	0.00485	0.00634	CcSEcCtD
Cyproheptadine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00484	0.00633	CcSEcCtD
Cyproheptadine—Urticaria—Fluorouracil—head and neck cancer	0.00467	0.0061	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—head and neck cancer	0.00466	0.00609	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—head and neck cancer	0.00465	0.00608	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—head and neck cancer	0.00459	0.00601	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—head and neck cancer	0.00457	0.00597	CcSEcCtD
Cyproheptadine—Convulsion—Docetaxel—head and neck cancer	0.0045	0.00589	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—head and neck cancer	0.00428	0.00559	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—head and neck cancer	0.00424	0.00555	CcSEcCtD
Cyproheptadine—Shock—Docetaxel—head and neck cancer	0.00417	0.00546	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00415	0.00543	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—head and neck cancer	0.00414	0.00541	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—head and neck cancer	0.00404	0.00529	CcSEcCtD
Cyproheptadine—Diarrhoea—Fluorouracil—head and neck cancer	0.00402	0.00526	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—head and neck cancer	0.00396	0.00518	CcSEcCtD
Cyproheptadine—Dizziness—Fluorouracil—head and neck cancer	0.00389	0.00508	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—head and neck cancer	0.00384	0.00502	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—head and neck cancer	0.00381	0.00498	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—head and neck cancer	0.00377	0.00493	CcSEcCtD
Cyproheptadine—Vomiting—Fluorouracil—head and neck cancer	0.00374	0.00489	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—head and neck cancer	0.00373	0.00488	CcSEcCtD
Cyproheptadine—Rash—Fluorouracil—head and neck cancer	0.00371	0.00484	CcSEcCtD
Cyproheptadine—Dermatitis—Fluorouracil—head and neck cancer	0.0037	0.00484	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—head and neck cancer	0.00369	0.00482	CcSEcCtD
Cyproheptadine—Headache—Fluorouracil—head and neck cancer	0.00368	0.00481	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—head and neck cancer	0.00366	0.00478	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—head and neck cancer	0.00363	0.00474	CcSEcCtD
Cyproheptadine—Feeling abnormal—Docetaxel—head and neck cancer	0.0035	0.00457	CcSEcCtD
Cyproheptadine—Nausea—Fluorouracil—head and neck cancer	0.00349	0.00456	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—head and neck cancer	0.00304	0.00398	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—head and neck cancer	0.0029	0.00379	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—head and neck cancer	0.0028	0.00367	CcSEcCtD
Cyproheptadine—Vomiting—Docetaxel—head and neck cancer	0.0027	0.00353	CcSEcCtD
Cyproheptadine—Rash—Docetaxel—head and neck cancer	0.00267	0.0035	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—head and neck cancer	0.00267	0.00349	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—head and neck cancer	0.00266	0.00347	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—head and neck cancer	0.00252	0.00329	CcSEcCtD
Cyproheptadine—HRH1—nose—head and neck cancer	0.000944	0.182	CbGeAlD
Cyproheptadine—HTR2A—trigeminal nerve—head and neck cancer	0.000619	0.119	CbGeAlD
Cyproheptadine—HTR2A—cranial nerve—head and neck cancer	0.000441	0.0851	CbGeAlD
Cyproheptadine—CHRM3—exocrine gland—head and neck cancer	0.000334	0.0646	CbGeAlD
Cyproheptadine—CHRM1—parotid gland—head and neck cancer	0.000195	0.0376	CbGeAlD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000191	0.000828	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00019	0.000826	CbGpPWpGaD
Cyproheptadine—CHRM1—saliva-secreting gland—head and neck cancer	0.000186	0.036	CbGeAlD
Cyproheptadine—HTR6—head—head and neck cancer	0.000185	0.0357	CbGeAlD
Cyproheptadine—DRD2—Signaling Pathways—YAP1—head and neck cancer	0.000175	0.00076	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—YAP1—head and neck cancer	0.000172	0.000748	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—YAP1—head and neck cancer	0.000172	0.000746	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—YAP1—head and neck cancer	0.000171	0.000744	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—YAP1—head and neck cancer	0.000171	0.000741	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—YAP1—head and neck cancer	0.000169	0.000734	CbGpPWpGaD
Cyproheptadine—CHRM3—saliva-secreting gland—head and neck cancer	0.000167	0.0322	CbGeAlD
Cyproheptadine—HTR6—GPCR downstream signaling—IL2—head and neck cancer	0.000155	0.000676	CbGpPWpGaD
Cyproheptadine—CHRM1—trachea—head and neck cancer	0.000144	0.0278	CbGeAlD
Cyproheptadine—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	0.000142	0.000617	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL2—head and neck cancer	0.000141	0.000614	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PTGS2—head and neck cancer	0.000137	0.000594	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL2—head and neck cancer	0.000129	0.00056	CbGpPWpGaD
Cyproheptadine—HTR2A—neck—head and neck cancer	0.000127	0.0245	CbGeAlD
Cyproheptadine—CHRM3—Metabolism—TYMS—head and neck cancer	0.000122	0.000532	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOTCH1—head and neck cancer	0.000121	0.000527	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GSTM1—head and neck cancer	0.000121	0.000526	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PTEN—head and neck cancer	0.000119	0.000518	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GPX1—head and neck cancer	0.000116	0.000504	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	0.000115	0.0005	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP1A1—head and neck cancer	0.000115	0.000499	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL2—head and neck cancer	0.000114	0.000498	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—MAPK3—head and neck cancer	0.000114	0.000493	CbGpPWpGaD
Cyproheptadine—HTR2B—thyroid gland—head and neck cancer	0.000113	0.0218	CbGeAlD
Cyproheptadine—CHRM2—head—head and neck cancer	0.000111	0.0214	CbGeAlD
Cyproheptadine—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	0.000111	0.000481	CbGpPWpGaD
Cyproheptadine—HRH1—connective tissue—head and neck cancer	0.000109	0.021	CbGeAlD
Cyproheptadine—HTR6—Signaling by GPCR—MAPK1—head and neck cancer	0.000108	0.000469	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—EGFR—head and neck cancer	0.000108	0.000469	CbGpPWpGaD
Cyproheptadine—HTR2C—head—head and neck cancer	0.000107	0.0206	CbGeAlD
Cyproheptadine—HTR1A—Signaling by GPCR—IL2—head and neck cancer	0.000105	0.000454	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL2—head and neck cancer	0.000104	0.000452	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	0.000104	0.00045	CbGpPWpGaD
Cyproheptadine—HRH1—epithelium—head and neck cancer	0.000103	0.02	CbGeAlD
Cyproheptadine—HTR6—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000103	0.000449	CbGpPWpGaD
Cyproheptadine—CHRM3—thyroid gland—head and neck cancer	0.000102	0.0196	CbGeAlD
Cyproheptadine—DRD2—GPCR downstream signaling—IL2—head and neck cancer	0.000101	0.000439	CbGpPWpGaD
Cyproheptadine—CHRM1—head—head and neck cancer	0.000101	0.0195	CbGeAlD
Cyproheptadine—HTR2B—head—head and neck cancer	0.0001	0.0194	CbGeAlD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	9.94e-05	0.000432	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL2—head and neck cancer	9.92e-05	0.000431	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL2—head and neck cancer	9.89e-05	0.00043	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	9.86e-05	0.000429	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL2—head and neck cancer	9.86e-05	0.000429	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	9.86e-05	0.000428	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL2—head and neck cancer	9.76e-05	0.000424	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	9.42e-05	0.000409	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—PIK3CA—head and neck cancer	9.37e-05	0.000407	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL2—head and neck cancer	9.18e-05	0.000399	CbGpPWpGaD
Cyproheptadine—HRH1—trachea—head and neck cancer	9.14e-05	0.0177	CbGeAlD
Cyproheptadine—HTR2A—connective tissue—head and neck cancer	9.09e-05	0.0176	CbGeAlD
Cyproheptadine—HTR2A—Signaling by GPCR—IL2—head and neck cancer	9.03e-05	0.000392	CbGpPWpGaD
Cyproheptadine—CHRM3—head—head and neck cancer	9.03e-05	0.0174	CbGeAlD
Cyproheptadine—HRH1—Signaling by GPCR—IL2—head and neck cancer	9.01e-05	0.000392	CbGpPWpGaD
Cyproheptadine—HTR1A—head—head and neck cancer	8.99e-05	0.0174	CbGeAlD
Cyproheptadine—CHRM1—Signaling by GPCR—IL2—head and neck cancer	8.98e-05	0.00039	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	8.97e-05	0.00039	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL2—head and neck cancer	8.95e-05	0.000389	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	8.93e-05	0.000388	CbGpPWpGaD
Cyproheptadine—SLC6A2—head—head and neck cancer	8.91e-05	0.0172	CbGeAlD
Cyproheptadine—CHRM2—Signaling by GPCR—IL2—head and neck cancer	8.86e-05	0.000385	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—HRAS—head and neck cancer	8.67e-05	0.000377	CbGpPWpGaD
Cyproheptadine—HTR2A—epithelium—head and neck cancer	8.63e-05	0.0167	CbGeAlD
Cyproheptadine—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	8.55e-05	0.000372	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—head and neck cancer	8.43e-05	0.000366	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PIK3CA—head and neck cancer	8.4e-05	0.000365	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	8.4e-05	0.000365	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	8.36e-05	0.000363	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—head and neck cancer	8.34e-05	0.000363	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCND1—head and neck cancer	8.13e-05	0.000353	CbGpPWpGaD
Cyproheptadine—DRD2—head—head and neck cancer	8.12e-05	0.0157	CbGeAlD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	7.99e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	7.99e-05	0.000347	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	7.95e-05	0.000346	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	7.95e-05	0.000346	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	7.91e-05	0.000344	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	7.88e-05	0.000342	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PTEN—head and neck cancer	7.85e-05	0.000341	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	7.75e-05	0.000337	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	7.73e-05	0.000336	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOTCH1—head and neck cancer	7.71e-05	0.000335	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	7.7e-05	0.000335	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOTCH1—head and neck cancer	7.68e-05	0.000334	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—head and neck cancer	7.66e-05	0.000333	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	7.64e-05	0.000332	CbGpPWpGaD
Cyproheptadine—HTR2A—trachea—head and neck cancer	7.63e-05	0.0147	CbGeAlD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—head and neck cancer	7.61e-05	0.000331	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOTCH1—head and neck cancer	7.61e-05	0.000331	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	7.6e-05	0.00033	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCND1—head and neck cancer	7.42e-05	0.000323	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	7.38e-05	0.000321	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	7.26e-05	0.000316	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	7.24e-05	0.000315	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK3—head and neck cancer	7.22e-05	0.000314	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK3—head and neck cancer	7.2e-05	0.000313	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTEN—head and neck cancer	7.16e-05	0.000311	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK3—head and neck cancer	7.13e-05	0.00031	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—head and neck cancer	7.09e-05	0.000308	CbGpPWpGaD
Cyproheptadine—HTR2B—lymph node—head and neck cancer	7.03e-05	0.0136	CbGeAlD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	7.02e-05	0.000305	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—head and neck cancer	7.02e-05	0.000305	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	7.02e-05	0.000305	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	6.99e-05	0.000304	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	6.94e-05	0.000302	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	6.91e-05	0.0003	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	6.91e-05	0.0003	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	6.9e-05	0.0003	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	6.89e-05	0.0003	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	6.89e-05	0.0003	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—head and neck cancer	6.87e-05	0.000299	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—head and neck cancer	6.87e-05	0.000299	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—head and neck cancer	6.87e-05	0.000298	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—head and neck cancer	6.85e-05	0.000298	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—head and neck cancer	6.85e-05	0.000298	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—head and neck cancer	6.82e-05	0.000297	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	6.78e-05	0.000295	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	6.78e-05	0.000295	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	6.71e-05	0.000292	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK3—head and neck cancer	6.71e-05	0.000291	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	6.6e-05	0.000287	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	6.59e-05	0.000286	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	6.56e-05	0.000285	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—head and neck cancer	6.54e-05	0.000284	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	6.48e-05	0.000282	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	6.47e-05	0.000281	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	6.42e-05	0.000279	CbGpPWpGaD
Cyproheptadine—HRH1—head—head and neck cancer	6.42e-05	0.0124	CbGeAlD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—head and neck cancer	6.41e-05	0.000278	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	6.39e-05	0.000278	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—head and neck cancer	6.38e-05	0.000277	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—head and neck cancer	6.38e-05	0.000277	CbGpPWpGaD
Cyproheptadine—SLC6A2—lymph node—head and neck cancer	6.24e-05	0.0121	CbGeAlD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	6.24e-05	0.000271	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	6.21e-05	0.00027	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—head and neck cancer	6.17e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—head and neck cancer	6.14e-05	0.000267	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	6.12e-05	0.000266	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	6.09e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	6.02e-05	0.000262	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	5.99e-05	0.000261	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	5.99e-05	0.00026	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	5.98e-05	0.00026	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—head and neck cancer	5.96e-05	0.000259	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—head and neck cancer	5.95e-05	0.000259	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—head and neck cancer	5.94e-05	0.000258	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	5.88e-05	0.000256	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	5.82e-05	0.000253	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—head and neck cancer	5.82e-05	0.000253	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	5.81e-05	0.000253	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	5.78e-05	0.000251	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	5.67e-05	0.000246	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	5.64e-05	0.000245	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	5.64e-05	0.000245	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	5.54e-05	0.000241	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	5.54e-05	0.000241	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	5.53e-05	0.000241	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	5.52e-05	0.00024	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	5.5e-05	0.000239	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	5.48e-05	0.000238	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	5.44e-05	0.000237	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—head and neck cancer	5.42e-05	0.000236	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	5.39e-05	0.000234	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	5.38e-05	0.000234	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	5.36e-05	0.000233	CbGpPWpGaD
Cyproheptadine—HTR2A—head—head and neck cancer	5.36e-05	0.0103	CbGeAlD
Cyproheptadine—HTR6—Signaling Pathways—TP53—head and neck cancer	5.36e-05	0.000233	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	5.35e-05	0.000232	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—head and neck cancer	5.33e-05	0.000232	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—head and neck cancer	5.32e-05	0.000231	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—head and neck cancer	5.31e-05	0.000231	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	5.29e-05	0.00023	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—head and neck cancer	5.29e-05	0.00023	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—head and neck cancer	5.28e-05	0.00023	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	5.25e-05	0.000228	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—head and neck cancer	5.24e-05	0.000228	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	5.22e-05	0.000227	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	5.2e-05	0.000226	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	5.2e-05	0.000226	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—head and neck cancer	5.19e-05	0.000226	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	5.17e-05	0.000225	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	5.17e-05	0.000225	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—head and neck cancer	5.16e-05	0.000224	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—head and neck cancer	5.12e-05	0.000223	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	5.11e-05	0.000222	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—head and neck cancer	5.1e-05	0.000222	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	5.05e-05	0.00022	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	5.02e-05	0.000218	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—head and neck cancer	5.01e-05	0.000218	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	4.99e-05	0.000217	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	4.98e-05	0.000216	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	4.98e-05	0.000216	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	4.96e-05	0.000216	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	4.94e-05	0.000215	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	4.93e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	4.9e-05	0.000213	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—head and neck cancer	4.89e-05	0.000213	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	4.89e-05	0.000212	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	4.87e-05	0.000212	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	4.85e-05	0.000211	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	4.81e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	4.72e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	4.72e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	4.7e-05	0.000204	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	4.7e-05	0.000204	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	4.68e-05	0.000203	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	4.61e-05	0.0002	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—head and neck cancer	4.56e-05	0.000198	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	4.53e-05	0.000197	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	4.52e-05	0.000197	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—head and neck cancer	4.52e-05	0.000197	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	4.51e-05	0.000196	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	4.49e-05	0.000195	CbGpPWpGaD
Cyproheptadine—HRH1—lymph node—head and neck cancer	4.49e-05	0.00867	CbGeAlD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	4.49e-05	0.000195	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—head and neck cancer	4.48e-05	0.000195	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	4.46e-05	0.000194	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	4.45e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	4.45e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	4.41e-05	0.000192	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	4.36e-05	0.000189	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	4.29e-05	0.000186	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	4.28e-05	0.000186	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	4.26e-05	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	4.25e-05	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	4.21e-05	0.000183	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—head and neck cancer	4.2e-05	0.000182	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	4.15e-05	0.00018	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—head and neck cancer	4.15e-05	0.00018	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	4.13e-05	0.000179	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	4.1e-05	0.000178	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	4.08e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	4.08e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	4.08e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	4.07e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—head and neck cancer	4.07e-05	0.000177	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	4.06e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	4.06e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	4.05e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	4.04e-05	0.000176	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	4.01e-05	0.000174	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	4.01e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—head and neck cancer	3.96e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—head and neck cancer	3.94e-05	0.000171	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	3.79e-05	0.000165	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	3.77e-05	0.000164	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	3.6e-05	0.000156	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	3.54e-05	0.000154	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	3.53e-05	0.000154	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	3.52e-05	0.000153	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	3.51e-05	0.000153	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—head and neck cancer	3.48e-05	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	3.48e-05	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—head and neck cancer	3.43e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—head and neck cancer	3.42e-05	0.000149	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—head and neck cancer	3.42e-05	0.000149	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—head and neck cancer	3.41e-05	0.000148	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—head and neck cancer	3.4e-05	0.000148	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—head and neck cancer	3.36e-05	0.000146	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	3.35e-05	0.000146	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	3.33e-05	0.000145	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—head and neck cancer	3.33e-05	0.000145	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	3.28e-05	0.000142	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—head and neck cancer	3.27e-05	0.000142	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	3.26e-05	0.000142	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	3.25e-05	0.000141	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	3.22e-05	0.00014	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—head and neck cancer	2.94e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	2.89e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—head and neck cancer	2.89e-05	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	2.88e-05	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	2.87e-05	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	2.84e-05	0.000123	CbGpPWpGaD
